Atrophic Vaginal, also known as atrophic vaginitis or urogenital atrophy, is an inflammatory disease of the vagina due to thinning and shrinking of the tissues. The most common cause of diseases is lack of reproductive hormone, estrogen, which happens naturally during perimenopause and increased in postmenopause.
Browse Full Report with TOC:
Global postmenopausal vaginal atrophy treatment and drug market has experienced significant growth over recent years. Some of the major growth drivers for market are launch of novel, non estrogen based drugs, such as Vaginorm and Osphena, increased healthcare reforms under the Affordable Care Act (ACA), cultural and social attitudes towards sexuality and aging population. However, invasion of low price generics drugs through licensing agreements is acting as a major restraint for the market. Some of the major drug brands for treatment of the disease are Colpotrophine, Vagifem, Estring, Estrace and Premarin.
Global postmenopausal vaginal atrophy treatment and drug market is based on epidemiology of vaginal atrophy in different regions of the world and it is segmented on the basis of age specific prevalence and severity. Merck, Pfizer, Novartis, Mylan and Bristol Myers are some of the major companies operating in this market.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
More Report on Pharmaceutical Market:
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
90 State Street,
Albany NY – 12207
Browse Market Research Report:-